Resultados de búsqueda - Nature Publishing Group :: Descubridor de recursos de la Universidad Veracruzana

221

TGF-beta expression in the human colon: differential immunostaining along crypt epithelium.

por Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M., Moorghen, M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

TGF-beta expression in the human colon: differential immunostaining along crypt epithelium.

222

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.

por Fisken, J., Leonard, R. C., Stewart, M., Beattie, G. J., Sturgeon, C., Aspinall, L., Roulston, J. E.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.

223

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

por Steyerberg, E. W., Keizer, H. J., Zwartendijk, J., Van Rijk, G. L., Van Groeningen, C. J., Habbema, J. D., Stoter, G.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

224

Uptake of cervical screening.

por Twaddle, S., McIlwaine, G.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

225

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

por Poller, D. N., Snead, D. R., Roberts, E. C., Galea, M., Bell, J. A., Gilmour, A., Elston, C. W., Blamey, R. W., Ellis, I. O.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

226

The modulation of radiation-induced damage to pig skin by essential fatty acids.

por Hopewell, J. W., Robbins, M. E., van den Aardweg, G. J., Morris, G. M., Ross, G. A., Whitehouse, E., Horrobin, D. F., Scott, C. A.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

The modulation of radiation-induced damage to pig skin by essential fatty acids.

227

HER-2/neu oncogene: what does amplification mean?

por Pavy, J. J., Descotes, F., Adessi, G. L.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

HER-2/neu oncogene: what does amplification mean?

228

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

por Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., Pinedo, H. M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

229

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

por Kjaer, S. K., de Villiers, E. M., Cağlayan, H., Svare, E., Haugaard, B. J., Engholm, G., Christensen, R. B., Møller, K. A., Poll, P., Jensen, H.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

230

Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

por Camplejohn, R. S., Brock, A., Barnes, D. M., Gillett, C., Raikundalia, B., Kreipe, H., Parwaresch, M. R.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

231

Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

por Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

232

Wilms' tumour and parental age: a report from the National Wilms' Tumour Study.

por Olson, J. M., Breslow, N. E., Beckwith, J. B.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Wilms' tumour and parental age: a report from the National Wilms' Tumour Study.

233

Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progen...

por Shimizu, E., Yamamoto, A., Takahashi, Y., Maniwa, K., Yoshida, S., Mukai, J., Takaue, Y., Ogura, T.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.

234

Does the month of diagnosis affect survival of cancer patients?

por Sankila, R., Joensuu, H., Pukkala, E., Toikkanen, S.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Does the month of diagnosis affect survival of cancer patients?

235

P glycoprotein (P-gp) and drug resistance--time for reappraisal?

por Kaye, S. B.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

P glycoprotein (P-gp) and drug resistance--time for reappraisal?

236

Advanced breast cancer: use of resources and cost implications.

por Richards, M. A., Braysher, S., Gregory, W. M., Rubens, R. D.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Advanced breast cancer: use of resources and cost implications.

237

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

por De Giovanni, C., Lollini, P. L., Dolcetti, R., Landuzzi, L., Nicoletti, G., D'Andrea, E., Scotland, K., Nanni, P.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

238

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.

por Luqmani, Y. A., Campbell, T., Soomro, S., Shousha, S., Rio, M. C., Coombes, R. C.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.

239

Prognostic significance of cathepsin-D in patients with breast cancer.

por Winstanley, J. H., Leinster, S. J., Cooke, T. G., Westley, B. R., Platt-Higgins, A. M., Rudland, P. S.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Prognostic significance of cathepsin-D in patients with breast cancer.

240

Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin.

por Plumb, J. A., Luo, W., Kerr, D. J.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin.

Limitar resultados